Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 23338680)

1.

Tetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancer.

Byun JM, Jeong DH, Lee DS, Kim JR, Park SG, Kang MS, Kim YN, Lee KB, Sung MS, Kim KT.

Oncol Rep. 2013 Apr;29(4):1540-6. doi: 10.3892/or.2013.2243. Epub 2013 Jan 18.

PMID:
23338680
2.

Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.

Chung WH, Sung BH, Kim SS, Rhim H, Kuh HJ.

Int J Oncol. 2009 Jun;34(6):1669-79.

PMID:
19424586
3.

Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.

Gwak HS, Park MJ, Park IC, Woo SH, Jin HO, Rhee CH, Jung HW.

J Neurosurg. 2014 Dec;121(6):1483-91. doi: 10.3171/2014.8.JNS131991. Epub 2014 Oct 10.

PMID:
25303017
4.

Combination of arsenic trioxide and chemotherapy in small cell lung cancer.

Zheng CY, Lam SK, Li YY, Fong BM, Mak JC, Ho JC.

Lung Cancer. 2013 Nov;82(2):222-30. doi: 10.1016/j.lungcan.2013.08.022. Epub 2013 Sep 3.

PMID:
24041618
5.

Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.

Jurado R, Lopez-Flores A, Alvarez A, García-López P.

Oncol Rep. 2009 Nov;22(5):1237-45.

PMID:
19787245
6.

Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.

Straughn JM Jr, Oliver PG, Zhou T, Wang W, Alvarez RD, Grizzle WE, Buchsbaum DJ.

Gynecol Oncol. 2006 Apr;101(1):46-54. Epub 2005 Nov 4.

PMID:
16271751
7.

HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.

Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Rivera BK, Kálai T, Hideg K, Kuppusamy P.

Cancer Biol Ther. 2011 Nov 1;12(9):837-45. doi: 10.4161/cbt.12.9.17713. Epub 2011 Nov 1.

8.

[Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].

Zhang Y, Lin C, Qian HL, Lang JH, Fu M, Zhang XY, Liang X, Duan H, Xiang Y.

Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):25-9. Chinese.

PMID:
17575689
9.

Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.

Yang YI, Kim JH, Lee KT, Choi JH.

Gynecol Oncol. 2011 Dec;123(3):588-96. doi: 10.1016/j.ygyno.2011.08.031. Epub 2011 Sep 25.

PMID:
21945308
10.

A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.

Cao W, Li XQ, Wang X, Fan HT, Zhang XN, Hou Y, Liu SB, Mei QB.

Phytomedicine. 2010 Jul;17(8-9):598-605. doi: 10.1016/j.phymed.2009.12.014. Epub 2010 Jan 25.

PMID:
20092988
11.

Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.

Casagrande N, De Paoli M, Celegato M, Borghese C, Mongiat M, Colombatti A, Aldinucci D.

Gynecol Oncol. 2013 Dec;131(3):744-52. doi: 10.1016/j.ygyno.2013.08.041. Epub 2013 Sep 10.

PMID:
24029417
12.

A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.

Wang W, Adachi M, Zhang R, Zhou J, Zhu D.

Pancreas. 2009 May;38(4):e114-23. doi: 10.1097/MPA.0b013e3181a0b6f2.

PMID:
19342982
13.

Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.

Ma X, Zhang J, Liu S, Huang Y, Chen B, Wang D.

Cancer Chemother Pharmacol. 2012 Feb;69(2):485-94. doi: 10.1007/s00280-011-1722-9. Epub 2011 Aug 13.

PMID:
21842204
15.

Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.

Wen X, Li D, Zhang Y, Liu S, Ghali L, Iles RK.

Anticancer Drugs. 2012 Mar;23(3):280-7. doi: 10.1097/CAD.0b013e32834f1fd3.

PMID:
22245994
16.

Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.

Li H, Zhu X, Zhang Y, Xiang J, Chen H.

J Exp Clin Cancer Res. 2009 Aug 8;28:110. doi: 10.1186/1756-9966-28-110.

17.

In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.

Hamaguchi N, Hamada H, Miyoshi S, Irifune K, Ito R, Miyazaki T, Higaki J.

Cancer Sci. 2010 Sep;101(9):1955-64. doi: 10.1111/j.1349-7006.2010.01632.x.

PMID:
20608936
18.
19.

Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.

Yu J, Qian H, Li Y, Wang Y, Zhang X, Liang X, Fu M, Lin C.

Gynecol Oncol. 2007 Aug;106(2):400-6. Epub 2007 May 21.

PMID:
17512576
20.

Comparison of diarsenic oxide and tetraarsenic oxide on anticancer effects: relation to the apoptosis molecular pathway.

Chang HS, Bae SM, Kim YW, Kwak SY, Min HJ, Bae IJ, Lee YJ, Shin JC, Kim CK, Ahn WS.

Int J Oncol. 2007 May;30(5):1129-35.

PMID:
17390014
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk